camptothecin analog

An anticancer drug related in structure to camptothecin, a topoisomerase inhibitor. One such drug is aminocamptothecin.

English dictionary of cancer terms . 2015.

Look at other dictionaries:

  • List of oncology-related terms — This is a list of terms related to oncology. The original source for this list was the U.S. National Cancer Institute s public domain Dictionary of Cancer Terms . NOTOC 1 * 10 propargyl 10 deazaaminopterin * 12 O tetradecanoylphorbol 13 acetate * …   Wikipedia

  • GI14721 — An antitumor drug that belongs to the family of drugs called topoisomerase inhibitors. It is a camptothecin analog …   English dictionary of cancer terms

  • irinotecan — An anticancer drug that is a type of topoisomerase inhibitor. It is a camptothecin analog. Also called CPT 11 …   English dictionary of cancer terms

  • Paclitaxel — Systematic (IUPAC) name (2α,4α,5β,7β,10β,13α) 4,10 bis(acetyloxy) …   Wikipedia

  • SN-38 — chembox new ImageFile=SN 38.svg ImageSize= IUPACName= OtherNames=7 Ethyl 10 hydroxy camptothecin Section1=Chembox Identifiers CASNo=86639 52 3 PubChem=104842 SMILES=CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)O Section2=Chembox… …   Wikipedia

  • Gemcitabine — Systematic (IUPAC) name …   Wikipedia

  • Fluorouracil — Systematic (IUPAC) name 5 fluoro 1H pyrimidine 2,4 d …   Wikipedia

  • Nelarabine — Systematic (IUPAC) name (2R,3S,4R,5R) 2 (2 amino 6 methoxy purin 9 yl) 5 (hydroxymethyl)oxolane 3,4 diol Clinical data AHFS/ …   Wikipedia

  • Antimetabolite — The drug methotrexate (right) is an antimetabolite that interferes with the metabolism of folic acid (left). An antimetabolite is a chemical that inhibits the use of a metabolite, which is another chemical that is part of normal metabolism.[1] …   Wikipedia

  • Cladribine — Systematic (IUPAC) name 5 (6 amino 2 chloro purin 9 yl) 2 (hydroxymethyl)oxolan 3 ol Clinical data AHFS/Drugs.com …   Wikipedia

Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”

We are using cookies for the best presentation of our site. Continuing to use this site, you agree with this.